Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Clinical Psychiatry|May 13, 2022
Daily Dose Effects of Risperidone on Weight and Other Metabolic Parameters: A Prospective Cohort StudyMarianna Piras, Céline Dubath, Mehdi Gholam, et al.
Translational Psychiatry|March 27, 2024
Associations between antipsychotics-induced weight gain and brain networks of impulsivityClaire Grosu, Paul Klauser, Daniella Dwir, et al.
Schizophrenia Research|July 10, 2024
Aripiprazole dose associations with metabolic adverse effect: Results from a longitudinal studyMarianna Piras, Iris Popovic, Setareh Ranjbar, et al.
Translational Psychiatry|November 15, 2024
Psychotropic-induced weight gain and telomere length: results from a one-year longitudinal study and a large population-based cohortMarianna Piras, Jue Lin, Marie Catherine Sadler, et al.
Basic & Clinical Pharmacology & Toxicology|February 12, 2022
Olanzapine-associated dose-dependent alterations for weight and metabolic parameters in a prospective cohortGeorgios Schoretsanitis, Céline Dubath, Claire Grosu, et al.
Molecular Psychiatry|May 12, 2023
Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysisJennifer Sjaarda, Aurélie Delacrétaz, Céline Dubath, et al.
Schizophrenia Bulletin|July 15, 2025
Influence of CYP2D6 Genotypes and Phenotypes on the Plasma Levels and Clinical Response to AripiprazoleCécile Gras, Marianna Piras, Setareh Ranjbar, et al.
Frontiers in Psychiatry|January 6, 2022
Associations Between High Plasma Methylxanthine Levels, Sleep Disorders and Polygenic Risk Scores of Caffeine Consumption or Sleep Duration in a Swiss Psychiatric CohortNermine Laaboub, Mehdi Gholam, Guibet Sibailly, et al.
BMC Psychiatry|May 17, 2022
Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohortNermine Laaboub, Céline Dubath, Setareh Ranjbar, et al.
The Lancet Regional Health. Europe|August 30, 2022
The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samplesBenjamin I Perry, Frederik Vandenberghe, Nathalia Garrido-Torres, et al.
Pageof 2